Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

Clinical trial NCT06575296 · RECRUITING

Trial details

NCT number: NCT06575296
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemia Acute Leukemia of Ambiguous Lineage Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Childhood Acute Leukemia Childhood Acute Leukemia of Ambiguous Lineage Childhood Acute Lymphoblastic Leukemia Childhood Acute Myeloid Leukemia

Start date: 2024-12-06
Primary completion: 2028-04-29
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.